跳至主要内容
临床试验/NL-OMON24868
NL-OMON24868尚未招募不适用

The combined effect of chemoprophylaxis with rifampicin and immunoprophylaxis with BCG, in the prevention of leprosy in contacts: A randomized controlled trial.

- Erasmus MC, University Medical Center RotterdamDepartment of Public Health- The Leprosy Mission International Bangladesh0 个研究点目标入组 20,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20,000

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Around 1,300 consecutive leprosy patients will be enrolled. The diagnosis of leprosy is generally carried out according to the RHP guidelines, which follow those of the national leprosy control program. A medical officer confirms all leprosy cases included in the study, and this confirmation is written on the patient card.

排除标准

  • Exclusion criteria for patients are as follows:
  • 1. Any patient who refuses examination of contacts;

研究者

发起方
- Erasmus MC, University Medical Center RotterdamDepartment of Public Health- The Leprosy Mission International Bangladesh

相似试验